| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/03/2008 | US20080160522 Primer for Detecting Food Poisoning and Method for Rapid Detection of Food Born Pathogene |
| 07/03/2008 | US20080160521 Benzimidazolium dyes and their use as fluorescent chemosensors |
| 07/03/2008 | US20080160520 Methods and Composition for Diagnosing and Treating Cancer |
| 07/03/2008 | US20080160519 Using presence of allelic variation in apoptoic protease activating factor 1 (APAf1) gene as a diagnostic indicator of biopolar disorders |
| 07/03/2008 | US20080160518 Template sequences for propgation of preferential nucleic acids |
| 07/03/2008 | US20080160517 Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors |
| 07/03/2008 | US20080160516 Capture and detection format versatility for dipstick assays |
| 07/03/2008 | US20080160515 Use of C3a and Derivatives Thereof as a Biomarker for Colorectal Adenoma and/or Carcinoma; Method for Detection and Test System |
| 07/03/2008 | US20080160513 Characterization of Mcra Subunits and Uses Thereof |
| 07/03/2008 | US20080160512 Using bioinfomatic to characterize preferential nucleotide sequences; screening, classifying and detecting pathogen sequences |
| 07/03/2008 | US20080160511 Method and Substances For Isolating miRNAs |
| 07/03/2008 | US20080160510 Method of Detecting Carcinogenesis Caused by Hepatitis B Virus |
| 07/03/2008 | US20080160509 Assays for predicting and assessing predisposition to male pattern baldness |
| 07/03/2008 | US20080160508 Assay method and assay kit for virus respiratory infection |
| 07/03/2008 | US20080160507 Using cell-free protein synthesis mixture for use in translation and assembly of retroviral capsid and capsid intermediate particles |
| 07/03/2008 | US20080160506 Immunological analytical method and device for the determination of advanced glycosylation end products (AGEs) |
| 07/03/2008 | US20080160505 Diagnostic methods for age related macular degeneration |
| 07/03/2008 | US20080160504 Swallowing labelled substrate and monitoring incorporation of label in CO2, using variation in incorporation as evaluative tool in diagnosing/prognosing gastrointestinal disorders |
| 07/03/2008 | US20080160503 Using mass soectroscopy to detecting presence of preferential compounds in eye fluids after oral dosing |
| 07/03/2008 | US20080160502 Sealed, aseptic apparatus for collecting and culturing pathogens |
| 07/03/2008 | US20080160501 Plasma protein-binding ligands |
| 07/03/2008 | US20080160500 Low volume assay apparatus and method |
| 07/03/2008 | US20080160499 Non-denaturing lysis reagent |
| 07/03/2008 | US20080160498 Gel microdrops in genetic analysis |
| 07/03/2008 | US20080160109 Compositions and methods of their use for improving the condition and appearance of skin |
| 07/03/2008 | US20080160054 vectors or transgenic organisms; biosynthesis; derived from Physcomitrella |
| 07/03/2008 | US20080160046 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
| 07/03/2008 | US20080160040 Using papillomavirus minor capsid protein as tool in generating neutralizing antibodies which prevent and treat papillomal infection |
| 07/03/2008 | US20080160036 Protein fusion for use as antagonist to V-set domain containing T cell activation inhibitor 1(B7 H4); treating rheumatoid atrhritis, cardiomyopathy, skin, liver and connective tissue disorders |
| 07/03/2008 | US20080160023 Using type-1 peroxisomal targeting signal protein as tool in identifying modulators for prevention and treatment of heart ischemia, dietary obesity, fatty liver disease and hypercholesterolemia |
| 07/03/2008 | US20080160016 Compositions and methods of tolerizing a primate to an antigen |
| 07/03/2008 | US20080160011 Alpha-synuclein kinase |
| 07/03/2008 | US20080160010 Peptide That Elicits Neutralizing Antibodies Targeting the Hiv Co-Receptor |
| 07/03/2008 | US20080160002 Tumor necrosis factor cleaving agent for use in diagnosis, prevention and treatment of inflammatory disorders |
| 07/03/2008 | US20080159999 Cell differentiation; transfection; gene therapy; tissue engineering; Alzheimer's disease, Parkinson's disease, arthritis |
| 07/03/2008 | US20080159994 Using threee dimensionally encapsulated progenitor cell mixture as ttherapeutic tool in cartilage repair and reconstructive and cosmetic surgeries |
| 07/03/2008 | US20080159986 Modulators of the functions of receptors of the tnf/ngf receptor family and other proteins |
| 07/03/2008 | US20080159983 Using antisense, ,immunmoglobulin and/or ribozymal agents to treat blood disorders |
| 07/03/2008 | US20080156646 Nanostructured electrochemical biosensor with aptamer as molecular recognition probe |
| 07/03/2008 | DE102007006585B3 Method for identifying active substance complex, which modifies enzymatic characteristic of synaptosomal or synaptic effect local complex within range of synaptosomal or synaptic membrane, involves examining of synaptosome |
| 07/03/2008 | DE102006062619A1 Determining a cell-bound analyte in a liquid sample comprises using a device comprising a sample delivery zone, a porous membrane with an indicator zone having a binding element for the analyte, and an absorption zone |
| 07/03/2008 | DE102006062089A1 Molecular biology process system comprises a device for synthesis of receptor arrays, devices for performing fluidic steps, a detection unit and programmable control units |
| 07/03/2008 | DE102006059881A1 Ein Hochdurchsatzassay zur Identifizierung von Kinaseinhibitoren und Kinaseaktivatoren basierend auf der Messung der ATP-Hydrolyse A high throughput assay for the identification of kinase inhibitors and kinase activators based on the measurement of ATP hydrolysis |
| 07/03/2008 | DE10053781B4 Kernexportreportersystem Nuclear export reporter system |
| 07/03/2008 | CA2673531A1 Reduction of polyalanine-induced protein aggregates and toxicity by ubiquilin |
| 07/03/2008 | CA2673525A1 Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
| 07/03/2008 | CA2673029A1 Materials and methods for the generation of transcripts comprising modified nucleotides |
| 07/03/2008 | CA2673017A1 Methods and compositions for nucleic acid amplification |
| 07/03/2008 | CA2672638A1 Methods for modulating set and uses thereof |
| 07/03/2008 | CA2669916A1 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 07/03/2008 | CA2669571A1 Pesticide biomarker |
| 07/03/2008 | CA2667698A1 Genetically engineered biological indicator |
| 07/03/2008 | CA2661881A1 Biological organism identification product and methods |
| 07/02/2008 | EP1939778A2 Analyzing CGH data to identify aberrations |
| 07/02/2008 | EP1939627A1 Universal biosensor and methods of use |
| 07/02/2008 | EP1939625A2 Methods for ligand discovery |
| 07/02/2008 | EP1939622A1 Method of forming autoaggregate on microparticle and method of detecting target analyte |
| 07/02/2008 | EP1939304A1 Method of detecting pathogenic Legionella strains |
| 07/02/2008 | EP1939303A1 Method for detecting cyst nematodes |
| 07/02/2008 | EP1939297A1 Alzheimer's disease secretase |
| 07/02/2008 | EP1939293A2 Interferon-Like Protein ZCYTO21 |
| 07/02/2008 | EP1939292A2 Nucleic acids isolated in neuroblastoma |
| 07/02/2008 | EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/02/2008 | EP1939287A1 Gene transfer method specific to trophectodermal cell |
| 07/02/2008 | EP1939286A1 Novel peptides |
| 07/02/2008 | EP1939215A1 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 07/02/2008 | EP1939213A1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 07/02/2008 | EP1938838A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 07/02/2008 | EP1938105A1 Method to assess breast cancer risk |
| 07/02/2008 | EP1938102A2 Improved target ligand detection |
| 07/02/2008 | EP1938098A2 Universal rapid test and method for detection of tuberculosis in multiple host species |
| 07/02/2008 | EP1937850A2 Methods and compositions for labeling nucleic acids |
| 07/02/2008 | EP1937849A2 Methods and compositions for labeling nucleic acids |
| 07/02/2008 | EP1937848A2 In situ assembly of protein microarrays |
| 07/02/2008 | EP1937847A2 Compositions and methods to detect legionella pneumophila nucleic acid |
| 07/02/2008 | EP1937846A2 Systemic lupus erythematosus diagnostic assay |
| 07/02/2008 | EP1937845A2 Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer |
| 07/02/2008 | EP1937844A1 Probe for tagging valuables based on dna-metal complex |
| 07/02/2008 | EP1937843A1 POLYMORPHISMS IN PONl ARE ASSOCIATED WITH ELEVATED ALANINE AMINOTRANSFERASE LEVELS AFTER XIMELAGATRAN OR TACRINE ADMINISTRATION |
| 07/02/2008 | EP1937842A1 Association between hla-drb1* 07 allele and susceptibily to increased levels of alat following ximelagatran administration |
| 07/02/2008 | EP1937841A1 Polymorphisms in mgst3 are associated with elevated alat levels after ximelagatran treatment |
| 07/02/2008 | EP1937840A2 Diagnostic methods based on polymorphisms of glucosyltransferase-like protein |
| 07/02/2008 | EP1937839A1 Method for diagnosing thromboembolic disorders and coronary heart diseases |
| 07/02/2008 | EP1937838A1 Methods of using il-21 |
| 07/02/2008 | EP1937837A2 Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies |
| 07/02/2008 | EP1937836A1 Control of preservation by biomarkers |
| 07/02/2008 | EP1937835A1 Gins gene expression as marker for actively cycling cells and cell cycle phase |
| 07/02/2008 | EP1937834A1 Methods for the amplification, quantitation and identification of nucleic acids |
| 07/02/2008 | EP1937833A1 Identification of genes and their products which promote hybrid vigour or hybrid debility and uses thereof |
| 07/02/2008 | EP1937832A2 Method of manufacturing a diagnostic test strip |
| 07/02/2008 | EP1937831A1 Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosls |
| 07/02/2008 | EP1937830A2 Stabilized antimicrobial compositions and related methods of preparation |
| 07/02/2008 | EP1937828A1 Assessment of infectious bacteria |
| 07/02/2008 | EP1937816A1 Markers for diagnosis of cancer and its use |
| 07/02/2008 | EP1937706A2 Biomarkers associated with age-related macular degeneration |
| 07/02/2008 | EP1937702A2 Labeled nucleotide analogs and uses therefor |
| 07/02/2008 | EP1937314A2 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
| 07/02/2008 | EP1937306A2 Proteolysis resistant antibody preparations |
| 07/02/2008 | EP1937280A2 Compositions and methods for the diagnosis and therapy of bcl2-associated cancers |
| 07/02/2008 | EP1937279A2 Use of inhibitors of pi3k-c2a for the treatment of apoptosis-related disorders |